Xiaoxiao Wang

2.2k total citations · 2 hit papers
56 papers, 1.3k citations indexed

About

Xiaoxiao Wang is a scholar working on Oncology, Pathology and Forensic Medicine and Cancer Research. According to data from OpenAlex, Xiaoxiao Wang has authored 56 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Oncology, 17 papers in Pathology and Forensic Medicine and 14 papers in Cancer Research. Recurrent topics in Xiaoxiao Wang's work include Cancer Immunotherapy and Biomarkers (15 papers), Lymphoma Diagnosis and Treatment (12 papers) and CAR-T cell therapy research (8 papers). Xiaoxiao Wang is often cited by papers focused on Cancer Immunotherapy and Biomarkers (15 papers), Lymphoma Diagnosis and Treatment (12 papers) and CAR-T cell therapy research (8 papers). Xiaoxiao Wang collaborates with scholars based in China, Belgium and United States. Xiaoxiao Wang's co-authors include Jieyi Wang, Haidong Tang, Yang‐Xin Fu, Yang Wang, Yuan Zhang, Wei Liang, Jingya Guo, Lukasz K. Chlewicki, Ting Xu and Laurence Buisseret and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Xiaoxiao Wang

49 papers receiving 1.3k citations

Hit Papers

Facilitating T Cell Infiltration in Tumor Microenvironmen... 2016 2026 2019 2022 2016 2023 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoxiao Wang China 15 738 462 366 247 198 56 1.3k
Song‐Yang Wu China 14 693 0.9× 597 1.3× 571 1.6× 382 1.5× 264 1.3× 24 1.4k
Alexios Matikas Sweden 19 929 1.3× 276 0.6× 395 1.1× 413 1.7× 370 1.9× 92 1.4k
Sharad Ghamande United States 22 770 1.0× 254 0.5× 579 1.6× 216 0.9× 230 1.2× 114 1.7k
Amir Sonnenblick Israel 22 885 1.2× 234 0.5× 743 2.0× 450 1.8× 212 1.1× 92 1.6k
Hao‐Xiang Wu China 22 596 0.8× 251 0.5× 520 1.4× 393 1.6× 289 1.5× 38 1.3k
Jieyi Wang United States 18 662 0.9× 372 0.8× 407 1.1× 144 0.6× 150 0.8× 28 1.2k
Josie Ursini‐Siegel Canada 20 671 0.9× 321 0.7× 817 2.2× 300 1.2× 120 0.6× 41 1.4k
Josep Garcia Switzerland 12 442 0.6× 162 0.4× 473 1.3× 374 1.5× 354 1.8× 33 1.4k
Marion Thibaudin France 13 778 1.1× 630 1.4× 391 1.1× 259 1.0× 150 0.8× 25 1.4k

Countries citing papers authored by Xiaoxiao Wang

Since Specialization
Citations

This map shows the geographic impact of Xiaoxiao Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoxiao Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoxiao Wang more than expected).

Fields of papers citing papers by Xiaoxiao Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoxiao Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoxiao Wang. The network helps show where Xiaoxiao Wang may publish in the future.

Co-authorship network of co-authors of Xiaoxiao Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoxiao Wang. A scholar is included among the top collaborators of Xiaoxiao Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoxiao Wang. Xiaoxiao Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Xiaowen, Zhou Yu, Wei Xue, et al.. (2025). A case-control study on the link between trace element exposure in follicular fluid and premature ovarian insufficiency. Reproductive Toxicology. 135. 108947–108947.
2.
Wang, Jinfeng, Xiaoxiao Wang, Jianfei Shi, et al.. (2025). CD161, a promising prognostic biomarker in hepatocellular carcinoma, correlates with immune infiltration. PeerJ. 13. e19055–e19055.
3.
Venet, David, Ghizlane Rouas, Xiaoxiao Wang, et al.. (2024). Spatial transcriptomic and proteomic insight into Trop-2, HER2, and AR expression: A pathway to tailored therapies in triple-negative breast cancer.. Journal of Clinical Oncology. 42(16_suppl). e12576–e12576. 2 indexed citations
4.
Wang, Xiaoxiao, et al.. (2024). Hub Genes Involved in the Progression of Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma. Current Medicinal Chemistry. 32(23). 4786–4804. 1 indexed citations
5.
Sun, Ping, et al.. (2024). Two hub genes of bipolar disorder, a bioinformatics study based on the GEO database. IBRO Neuroscience Reports. 17. 122–130. 3 indexed citations
6.
Li, Siyu, et al.. (2024). Cardiovascular adverse events associated with antibody-drug conjugates (ADCs): a pharmacovigilance study based on the FAERS database. Frontiers in Pharmacology. 15. 1378010–1378010. 7 indexed citations
8.
Wu, Si, Yue Meng, Jun Zhang, et al.. (2023). The Role of Artificial Intelligence in Accurate Interpretation of HER2 Immunohistochemical Scores 0 and 1+ in Breast Cancer. Modern Pathology. 36(3). 100054–100054. 63 indexed citations
9.
Wang, Xiaoxiao, Lei Wen, Jing Liao, et al.. (2023). First‐line immunotherapy with anti‐PD‐1 antibody for extranodal NK/T‐cell lymphoma: A retrospective study. British Journal of Haematology. 202(4). 812–824. 4 indexed citations
10.
Wang, Xiaoxiao, L. Collet, Mattia Rediti, et al.. (2023). Predictive Biomarkers for Response to Immunotherapy in Triple Negative Breast Cancer: Promises and Challenges. Journal of Clinical Medicine. 12(3). 953–953. 33 indexed citations
11.
12.
Zhao, Yan, Yueping Liu, Yunlong Jia, et al.. (2022). Fibroblast activation protein in the tumor microenvironment predicts outcomes of PD-1 blockade therapy in advanced non-small cell lung cancer. Journal of Cancer Research and Clinical Oncology. 149(7). 3469–3483. 14 indexed citations
13.
Wang, Xiaoxiao, David Venet, Denis Larsimont, et al.. (2022). 1711P Spatial transcriptomics reveals substantial heterogeneity in TNBC tumor and stroma compartments with potential clinical implications. Annals of Oncology. 33. S1321–S1322. 1 indexed citations
14.
Shen, Yue, et al.. (2022). Advanced primary vaginal squamous cell carcinoma: A case report and literature review. Frontiers in Immunology. 13. 1007462–1007462. 2 indexed citations
15.
Li, Fang, Bibo Tan, Qiang Ji, et al.. (2020). Relationship between HER2 expression and tumor interstitial angiogenesis in primary gastric cancer and its effect on prognosis. Pathology - Research and Practice. 217. 153280–153280. 12 indexed citations
17.
Luan, Yan, Dafei Chai, Min Wang, et al.. (2016). A fully human monoclonal antibody targeting PD-L1 with potent anti-tumor activity. International Immunopharmacology. 31. 248–256. 14 indexed citations
18.
Wang, Jiangnan, Rong Ma, Ashok Sharma, et al.. (2015). Inflammatory Serum Proteins Are Severely Altered in Metastatic Gastric Adenocarcinoma Patients from the Chinese Population. PLoS ONE. 10(4). e0123985–e0123985. 10 indexed citations
19.
Wang, Xiaoxiao, Zuo‐Xi Li, Baoyi Yu, Kristof Van Hecke, & Guang‐Hua Cui. (2015). Tuning zinc(II) coordination architectures by rigid long bis(triazole) and different carboxylates: Synthesis, structures and fluorescence properties. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy. 149. 109–115. 18 indexed citations
20.
Wang, Xiaoxiao, Laurence Buisseret, Roland de Wind, et al.. (2014). Reproducibility of Assessing Immune Infiltration in Core Biopsies Compared to Primary Breast Tumors. Annals of Oncology. 25. i17–i17. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026